Morepen Laboratories Limited (MOREPENLAB) Financial Statements

13 Followers

Morepen Laboratories Limited Financial Overview

Morepen Laboratories Limited's market cap is currently ₹24.13B. The company's EPS TTM is ₹1.79; its P/E ratio is 20.54; and it has a dividend yield of 0.49%. Morepen Laboratories Limited is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	₹ 18.30B	₹ 17.02B	₹ 14.18B	₹ 15.42B	₹ 11.75B
Gross Profit	₹ 6.30B	₹ 6.18B	₹ 2.19B	₹ 4.81B	₹ 3.89B
Operating Income	₹ 3.16B	₹ 4.17B	₹ 484.61M	₹ 1.26B	₹ 924.27M
EBITDA	₹ 1.92B	₹ 1.73B	₹ 856.66M	₹ 1.57B	₹ 1.30B
Net Income	₹ 1.18B	₹ 961.60M	₹ 386.75M	₹ 1.02B	₹ 970.86M
Balance Sheet
Cash & Short-Term Investments	₹ 1.27B	₹ 169.45M	₹ 216.66M	₹ 158.03M	₹ 413.87M
Total Assets	₹ 17.78B	₹ 12.93B	₹ 11.10B	₹ 10.70B	₹ 8.58B
Total Debt	₹ 1.05B	₹ 289.99M	₹ 251.64M	₹ 1.33B	₹ 1.37B
Net Debt	₹ 557.35M	₹ 120.54M	₹ 34.98M	₹ 27.66M	₹ -243.41M
Total Liabilities	₹ 5.91B	₹ 4.46B	₹ 3.58B	₹ 4.92B	₹ 4.34B
Stockholders' Equity	₹ 11.56B	₹ 8.47B	₹ 7.53B	₹ 5.79B	₹ 4.25B
Cash Flow
Free Cash Flow	₹ -919.76M	₹ -79.61M	₹ -1.37B	₹ -1.25B	₹ 104.27M
Operating Cash Flow	₹ 320.57M	₹ 733.75M	₹ -911.71M	₹ -577.58M	₹ 508.26M
Investing Cash Flow	₹ -3.22B	₹ -833.00M	₹ -465.09M	₹ -316.79M	₹ -703.51M
Financing Cash Flow	₹ 3.00B	₹ 52.05M	₹ 1.44B	₹ 663.34M	₹ 472.73M

Currency in INR

Morepen Laboratories Limited Earnings and Revenue History

Income Statement >

Morepen Laboratories Limited Debt to Assets

Balance Sheet >

Morepen Laboratories Limited Cash Flow

Cash Flow >

Morepen Laboratories Limited Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >